NONPEPTIDE ANGIOTENSIN-II RECEPTOR ANTAGONISTS - INTRODUCTION

被引:13
作者
LEE, RJ
机构
[1] The Du Pont Merck Pharmaceutical Company, Wilming­ton, DE, 19880-0026
关键词
D O I
10.1093/ajh/4.4.271S
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
[No abstract available]
引用
收藏
页码:S271 / S272
页数:2
相关论文
共 11 条
[1]  
Dzau V.J., Pratt R.E., Renin-angiotensin system: Biology, physiology and pharmacology, Handbook of Experimental Cardiology, pp. D1631-D1661, (1986)
[2]  
Sealey J.E., Laragh J.H., The renin-angiotensin-aldosterone system for normal regulation of blood pressure and sodium and potassium homeostasis, Hypertension: Pathophysiology, Diagnosis and Management, pp. 1317-1987, (1990)
[3]  
Vallotton M.B., The renin-angiotensin system, Trends Pharmacol Sei, 8, pp. 69-74, (1987)
[4]  
Marsden P.A., Brenner B.M., Ballermann B.J., Mechanisms of angiotensin action on vascular smooth muscle, the adrenal and the kidney, Hypertension: Pathophysiology, Diagnosis and Management, pp. 1247-1272, (1990)
[5]  
Ondetti M.A., Rubin A., Cushman D.W., Design of specific inhibitors of angiotensin converting enzyme: A new class of orally active antihypertensive agents. Science (Washington, DC), 196, pp. 441-444, (1977)
[6]  
Patchett A., Harris E., Tristram E., Et al., A new class of angiotensin converting enzyme inhibitors, Nature (London), 260, pp. 280-283, (1980)
[7]  
Waeber B., Nussberger B.M., Brunner J.H., Angioteftsin-con-verting enzyme inhibitors in hypertension, Hypertension: Pathophysiology, Diagnosis and Management, pp. 2209-2232, (1990)
[8]  
A placebo-controlled trial of captopril in refractory chronic congestive heart failure, J am Coll Cardiol, 2, pp. 755-763, (1983)
[9]  
Effects of enalapril on mortality in severe congestive heart failure, N Engl J Med, 23, pp. 1429-1435, (1987)
[10]  
Ondetti M.A., Cushman D.W., Enzymes of the renin-angiotensin system and their inhibitors, Ann Rev Biochem, 51, pp. 238-308, (1982)